NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-340-2007-0-CN-20 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS CN DIV 201410133658.X Abandoned
NCI E-340-2007-0-EP-11 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS EP DIV 16175539.2 Abandoned
NCI E-340-2007-0-EP-03 MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS EP National Stage 09715064.3 Abandoned
NCI E-340-2007-0-JP-04 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS JP National Stage 2010-548904 Abandoned
NCI E-340-2007-0-CA-08 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS CA National Stage 2716938 Abandoned
NCI E-179-2008-0-US-01 The Identification Of A Novel Amidated Peptide Derived From The N-terminus Of Apelin-36 That Stimulates Endothelial Cell And Tumor Growth At Nanomolar Concentrations US 61/156,351 Abandoned
NIAID E-125-2009-0-US-01 Live Vaccine Strains of Francisella Tularensis with Defined Mutations: Composition and Method of Use US 61/156,173 Abandoned
NIA E-089-2009-0-US-01 Sperm-derived SPANX-B Is A Clinically Relevant Tumor Antigen That Is Expressed In human Tumors And Readily Recognized By Human CD4+ And CD8+ T Cells US 61/156,435 Abandoned
NIAID E-117-2006-0-US-07 Boris Isoforms And Methods Of Detecting And Treating Disease US National Stage 12/439,063 8206933 Issued PDF
NIMH E-169-2004-0-US-03 Reporter Plasmid Phage Packaging System For Detection Of Bacteria US National Stage 11/547,587 Abandoned
NCI E-104-2009-0-US-01 Diagnostic And Therapeutic Applications Of MicroRNAs Aberrantly Regalated In Lung Cancers From Never-smokers US 61/155,709 Abandoned
NIAID E-117-2006-0-CA-04 BORIS ISOFORMS AND METHODS OF DETECTING AND TREATING DISEASE CA National Stage 2662012 Issued
CC E-064-2010-0-US-01 METHOD, SYSTEM AND DEVICES FOR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) PROCEDURES US ORD 12/392,817 8632468 Issued PDF
NIAID E-115-2009-0-US-01 CD121a (IL-1 Receptor Type 1) On Activated Human FOXP3+ Regulatory T Cells US 61/155,430 Abandoned
NIAID E-281-2006-0-US-03 Rnase A Peptides, Fragments and Uses Thereof US National Stage 12/438,700 8748572 Abandoned PDF
NIAID E-095-2008-0-PCT-02 Use of Immunogenic Compositions for the Treatment or Prevention of Pathogen Infections PCT PCT PCT/US2009/001176 Expired
NIAID E-095-2008-0-EP-04 Use of Immunogenic Compositions for the Treatment or Prevention of Pathogen Infections EP National Stage 09712709.6 Abandoned
NIAID E-117-2006-0-JP-06 BORIS ISOFORMS AND METHODS OF DETECTING AND TREATING DISEASE JP National Stage 2009-526917 Abandoned
NIAID E-019-2007-2-KR-09 Vaccines Against Potential Pandemic Strains Of Influenza KR National Stage 10-2009-7003756 Abandoned
NIDDK E-149-2006-2-US-02 Compositions And Methods For Modifying Cellular Propoerties US National Stage 12/438,706 Abandoned
NCI E-231-2002-0-US-08 A Family of Related Compounds That Show Activity as Inhibitors of Ubiquitin Ligases (E3s), with Some Specificity Towards MDM2 US DIV 12/390,692 Abandoned
CC E-057-2009-0-US-01 Methods For Loading Contrast Agents Into Drug Containing Liposomes US 61/154,663 Abandoned
NCI E-065-2005-2-US-01 Novobiocin Analogues Having Modified Sugar Moieties US CIP 12/390,175 8212012 Expired PDF
NCI E-065-2005-3-US-01 Novobiocin Analogues US CIP 12/390,011 8212011 Expired PDF
NIDA E-264-2007-0-PCT-02 SNPs And Genes For Smoking Cessation Success PCT PCT PCT/US2009/034694 Expired
NIDA E-264-2007-0-EP-05 METHODS AND COMPOSITIONS FOR PREDICTING SUCCESS IN ADDICTIVE SUBSTANCE CESSATION AND FOR PREDICTING A RISK OF ADDICTION EP National Stage 09712205.5 Abandoned
NIA E-059-2006-0-JP-06 METHOD OF TREATING OR PREVENTING OXIDATIVE STRESS-RELATED DISEASE JP National Stage 2009-525774 Abandoned
NIDA E-264-2007-0-AU-03 SNPs And Genes For Smoking Cessation Success AU National Stage 2009215410 Abandoned
NIDA E-264-2007-0-CA-04 SNPs And Genes For Smoking Cessation Success CA National Stage 2723490 Abandoned
NIAID E-114-2009-0-US-01 Method And Medium For Host Cell-free (axenic) Growth Of Coxiella Burnetiia US 61/154,330 Abandoned
NIA E-219-2008-0-US-01 Milk Fat Globule Epidermal Growth Factor VIII (MFG-E8) And Other Secreted Proteins Increase Markedly With Aging In Rats, Non-human Primates, And Human Arteries And Modulate Arterial Aging And The Response To Arterial Injury US 61/154,329 Abandoned
NCI E-045-2009-0-US-01 Herceptin-based Chimeric Antigen Receptor And Use Of Same For The Treatment Of Cancer US 61/154,080 Abandoned
NINDS E-008-2009-0-US-01 ACXCL13 And Endothelin 2 Promote Myelination By Adult CNS Precursor
cell 		US 61/153,860 Abandoned
NIA E-059-2006-0-US-07 Method Of Treating Or Preventing Oxidative Stress-Related Disease US National Stage 12/377,881 Abandoned
NCI E-198-2006-0-US-03 Anti-H5N1 Influenza Activity Of The Antiviral Protein Cyanovirin-N (CV-N) US National Stage 12/377,875 Abandoned
NIAID E-086-2009-0-US-01 Synthetic HIV/SIV GAG Proteins and Uses Thereof US 61/153,622 Abandoned
NCI E-198-2006-0-EP-04 Anti-H5N1 Influenza Activity Of The Antiviral Protein Cyanovirin-N (CV-N) EP National Stage 07814209.8 Abandoned
NICHD E-032-2008-0-PCT-02 Use Of Saccharides Cross-reactive With Bacillus Anthracis Spore Glycoprotein As A Vaccine Against Anthrax. PCT PCT PCT/US2009/000995 Expired
NCI E-340-2008-0-US-01 Stratification Of Breast Cancer Patients Based On Chromosome 8p 11-12 Amplification Anti/or EIP4EBP1 Over-expression For Therapeutic Interventions With Rapamycin And Its Analogs Against Local Advanced And Metastatic Breast Cancer US 61/152,920 Abandoned
NCI E-007-2004-0-US-07 Pyrrolobenzodiazepine Derivatives, Compositions, Comprimising The Same And Methods Related Thereto US CON 12/370,856 7834005 Abandoned PDF
CC E-254-2007-0-US-02 Encapsulated Nanoparticles For Computed Tomography Imaging US ORD 12/371,472 Abandoned
NCI E-023-2009-0-US-01 A Molecular-Based Methods of Cancer Diagnosis and Prognosis US 61/152,597 Abandoned
NINDS E-143-2007-0-PCT-02 OCTANOIC ACID FORMULATIONS AND METHODS OF TREATMENT USING THE SAME PCT PCT PCT/US2009/000876 Expired
NINDS E-143-2007-0-US-03 Octanoic Acid Formulations And Methods Of Treatment Using The Same US National Stage 12/867,702 Abandoned
NINDS E-143-2007-0-EP-04 OCTANOIC ACID FORMULATIONS AND METHODS OF TREATMENT USING THE SAME EP National Stage 09710855.9 Abandoned
NIDCR E-063-2009-0-US-01 Serological Screening For HHV-8 Infection Using Antigen Mixtures US 61/152,058 Abandoned
NIAID E-124-2009-0-US-01 Influenza Hemagglutinin And Neuraminidase Variants US 61/152,094 Abandoned
NCI E-016-2008-0-PCT-02 Modified SugarSubstrates and Methods of Use PCT PCT PCT/US2009/33842 Abandoned
NIA E-205-2006-2-CA-04 Preparation Of (R,R)-Fenoterol And (R,R)- Or (R,S)- Fenoterol Analogues And Their Use In Treating Congestive Heart Failure CA National Stage 2660707 Issued
NCI E-003-2008-0-AU-05 Methods Of Obtaining Antigen-Specific T Cell Populations AU National Stage 2009214980 Abandoned